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Abstract
Introduction: The clinical usefulness of baroreflex sensitivity (BRS) in the early detection of autonomic dysfunction in patients with
diabetes is not well established. The aim of the study was the evaluation of BRS in subjects with type 1 diabetes with and without cardio-
vascular autonomic neuropathy (CAN).
Material and methods: The group examined consisted of 39 patients with type 1 diabetes (mean age 30.5 ± 8.8 years; diabetes duration
12.1 ± 6.9 years; BMI 23.7 ± 2.8 kg/m2; HbA1c 7.6 ± 1.9%). The control group consisted of 18 sex and age–matched healthy adults. Blood
pressure, heart rate and chest respiratory movements were monitored continuously by non-invasive means (Portapres). In order to reco-
gnise CAN standard Ewing tests were performed. BRS was assessed in the lying (L-BRS) and standing (S-BRS) positions by the frequency
domain technique.
Results: Ten patients (25.6%) had CAN (the CAN(+) group). In the CAN(+) group BRS was significantly lower than in the CAN(–) group
in the lying and standing positions (respectively L-BRS 4.4 ± 2.1 vs. 10.0 ± 4.9 ms/mm Hg; p < 0.05; S-BRS 3.3 ± 1.6 vs. 7.0 ± 2.2 ms/mm Hg
p < 0.001). BRS did not differ significantly between the CAN(–) and control group (respectively L-BRS 10.0 ± 4.9 vs. 13.1 ± 5.5 ms/mm Hg
p=NS; S-BRS 7.0 ± 2.2 vs. 7.9 ± 4.0 ms/mm Hg p = NS).
Conclusions: BRS differentiated well the subjects with CAN from the group without CAN. However, the study did not enable us to
confirm the value of BRS in the early detection of autonomic dysfunction among patients with type 1 diabetes who showed no abnorma-
lities in standard cardiovascular tests. (Pol J Endocrinol 2008; 59 (5): 398–402)
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Streszczenie
Wstęp: Przydatność kliniczna oceny wrażliwości odruchu z baroreceptorów tętniczych (BRS, baroreflex sensitivity) we wczesnym rozpo-
znawaniu dysfunkcji układu autonomicznego u chorych z cukrzycą nie jest do końca ustalona. Celem pracy była ocena BRS w grupie
chorych z cukrzycą typu 1 w zależności od obecności neuropatii autonomicznej sercowo-naczyniowej (CAN) rozpoznanej na podstawie
klasycznych testów sercowo-naczyniowych.
Materiał i metody: Grupę badaną stanowiło 39 chorych z cukrzycą typu 1 (śr. wiek 30,5 ± 8,8 lat; czas trwania cukrzycy 12,1 ± 6,9 lat; BMI
23,7 ± 2,8 kg/m2; HbA1c 7,6 ± 1,9%). Grupę kontrolną stanowiło 18 zdrowych osób dobranych pod względem płci i wieku. W badaniu
wykorzystano nieinwazyjny ciągły pomiar ciśnienia tętniczego (Portapress) z równoczesną rejestracją EKG i ruchów oddechowych klatki
piersiowej. W celu rozpoznania neuropatii sercowo-naczyniowej przeprowadzono testy Ewinga. Wrażliwość odruchu baroreceptorów
obliczono metodą analizy widmowej, w pozycji leżącej (L-BRS) i stojącej (S-BRS).
Wyniki: Neuropatię autonomiczną sercowo-naczyniową rozpoznano u 25,6% chorych z cukrzycą typu 1 (grupa CAN(+)). Osoby te
charakteryzowały się istotnie niższymi wartościami L-BRS i S-BRS w porównaniu z chorymi bez CAN (grupa CAN(–) (odpowiednio:
L-BRS 4,4 ± 2,1 vs. 10,0 ± 4,9 ms/mm Hg, p < 0,05; S-BRS 3,3 ± 1,6 vs. 7,0 ± 2,2 ms/mm Hg, p < 0,001). Nie stwierdzono istotnych
statystycznie różnic w BRS w grupie CAN(–) i w grupie kontrolnej (odpowiednio: L-BRS 10,0 ± 4,9 vs.13,1 ± 5,5 ms/mm Hg, p=NS; S-BRS
7,0 ± 2,2 vs. 7,9 ± 4,0 ms/mm Hg, p = NS).
Wnioski: Wrażliwość odruchu baroreceptorów różnicowała dobrze chorych z cukrzycą i CAN od chorych bez tego powikłania. W bada-
niu nie potwierdzono jednak znaczenia oceny BRS we wczesnym wykrywaniu zaburzeń w funkcjonowaniu układu autonomicznego serca
u chorych z cukrzycą typu 1 i prawidłowymi wynikami klasycznych testów sercowo-naczyniowych. (Endokrynol Pol 2008; 59 (5): 398–402)
Słowa kluczowe: wrażliwość odruchu z baroreceptorów tętniczych, cukrzyca typu 1, neuropatia autonomiczna sercowo-naczyniowa
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Introduction
Cardiovascular autonomic neuropathy (CAN) is a com-
mon but probably very often overlooked complication
of diabetes [1]. The reported prevalence of CAN varies
depending on the patient cohort studied, the testing
modalities selected and the criteria used to define CAN.
On the basis of the EURODIAB IDDM Complications
Study CAN was clinically identified in 36% of patients
with type 1 diabetes [2]. Prospective studies have docu-
mented an increased risk of mortality among subjects
with CAN, compared to individuals without CAN [3–5].
This increased mortality has been attributed to an incre-
ased incidence of silent myocardial infarction, risk of sud-
den cardiac death and cardiovascular disease [5]. Since
autonomic neuropathy is associated with increased mor-
tality, early detection of this complication is essential.
Symptoms of CAN are often non-specific and should
not be considered markers of its presence [6, 7]. Cardio-
vascular autonomic neuropathy is usually examined in-
directly using cardiovascular reflex tests. It is generally
accepted that the diagnosis of CAN should be based on
the results of a battery of autonomic tests. The consen-
sus statement of the San Antonio Conference held in 1988
recommended the battery of five cardiovascular reflex
tests proposed by Ewing and Clarke for diagnosing CAN
[8, 9]. These tests are still recommended for the routine
screening and monitoring of the progression of CAN [10].
Cardiovascular autonomic function tests, although
useful in clinical practice, have some limitations. These
tests must be rigorously standardised, require the co-
operation of the patients examined and are time-con-
suming. More simple and reliable methods of detecting
and quantifying cardiovascular dysfunction are of cli-
nical interest. Power spectral analysis of heart rate va-
riability has been reported to provide useful informa-
tion on autonomic function in diabetic patients [11–13].
With improved technology spontaneous baroreceptor
cardiac reflex sensitivity, otherwise known as barore-
flex sensitivity (BRS), is used to assess autonomic func-
tion in diabetic patients. Traditionally BRS has been as-
sessed by measuring the changes in the RR interval pro-
duced in reflex to pharmacologically-induced changes
in blood pressure [14]. Non-invasive beat-to-beat blood
pressure measurement allows assessment to be made
of the relationship between spontaneous changes in
blood pressure and pulse interval in the time and fre-
quency domain. Baroreflex-mediated bradycardia se-
ems to be impaired in diabetic subjects relatively early,
before apparent abnormalities in standard cardiovascu-
lar tests can be detected [15–17]. On the other hand, it
was found that the BRS in diabetics with pathological
Ewing scores did not differ from the BRS in healthy
subjects [18].
The aim of this study was to evaluate BRS by power
spectral analysis in diabetic subjects with and without CAN
as recognised by standard cardiovascular reflex tests.
Material and methods
We studied 39 patients with type 1 diabetes, 27 women
(69.2%) and 12 men (30.8%) aged between 19 and
52 (mean ±  SD 30.5 ± 8.8) years. Patients were recru-
ited from the Department of Endocrinology and Dia-
betology of the Nicolaus Copernicus University. Patients
with arterial hypertension or a history or clinical mani-
festation of cardiovascular disease, renal failure or al-
cohol abuse were excluded from the study. Diabetic
complications were found in 22 patients. In 16 patients
(41%) we found sensorimotor distal symmetric polyneu-
ropathy, in 10 (25.5%) retinopathy and in 7 subjects
(17.9%) microalbuminuria. All patients were on inten-
sive insulin therapy. The control group consisted of
18 healthy non-diabetic volunteers who were matched
by age and sex. The characteristics of both groups are
shown in Table I.
The study protocol was approved by the local Ethics
Committee and written informed consent was obtained
from each subject. The study was performed in the
morning, in a quiet room with the temperature con-
trolled between 22 and 24°C. Subjects attended the la-
boratory at least two hours after a light breakfast, befo-
re which the usual morning insulin dose had been in-
jected. They were asked to avoid physical exercise,
stress, alcohol, coffee and smoking for 12 hours before
Table I. The characteristics of the diabetic and control subjects
Tabela I. Charakterystyka grupy chorych na cukrzycę i grupy
kontrolnej
Diabetic Control p
patients subjects
n=39 n=18
Male/female 27/12 12/6 –
Age (years) 30.5±8.8 31.4± 9.3 NS
Height [cm] 170.3±8.7 170.9± 9.2 NS
Weight [kg] 69.3±12.9 64.7± 13.7 NS
BMI [kg/m2] 23.7±2.8 22.0± 3.32 < 0.05
Diabetes duration 12.1±6.9 – –
[years]
HbA1c (%) 7.6±1.9 – –
SBP [mm Hg] 111.4±18.5 112.7±8.4 NS
DBP [mm Hg] 61.9±11.4 61.0±10.0 NS
Data are shown as mean values ± SD; n — the number of subjects in
a given condition; BMI — body mass index; SBP — systolic blood pressure;
DBP — diastolic blood pressure (average values of the 1 min recording
by Portapres in the sitting position)
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Table II. Mean values of Ewing’s tests in the examined and
control groups
Tabela II. Średnie wartości parametrów mierzonych w testach
Ewinga w grupie badanej i kontrolnej
Test Diabetic Control p
patients  subjects
Deep breathing 26.5±10.0 26.5±6.3 NS
(HRmax–HRmin) [beats/min]
Valsalva ratio (Vmax/min) 1.65±0.26 1.54±0.32 NS
Standing (30:15 ratio) 1.44±0.3 1.61±0.2 < 0.05
Standing (DSBP) 15.9±9.7 16.4±11.8 NS
[mm Hg]
Handgrip (DDBP) 19.6±10.9 24.8±15.7 NS
[mm Hg]
Data are shown as mean values ± SD; HRmax–HRmin — the increase of
heart rate during the deep breathing test; Vmax/min — the ratio between the
longest RR interval after the Valsalva manoeuvre and the shortest during
the procedure; 30:15 — the ratio between the longest RR interval around
the 30th heart beat and the shortest around the 15th heart beat after standing;
DSBP — the difference between systolic blood pressure 1–2 min. after
standing up and systolic blood pressure in the supine position; DDBP
— the increase in diastolic blood pressure during the handgrip test
the study. Diabetic patients with hypoglycaemia during
the previous 24 hours were excluded from the study.
The assessment of baroreflex sensitivity
After resting for 20 minutes subjects underwent conti-
nuous recording of beat-to-beat blood pressure, ECG
and chest respiratory movements. Blood pressure was
non-invasively assessed by a volume-clamp technique
(Portapres TNO–TPD Biomedical Instrumentation,
Amsterdam, Netherlands). The accuracy of this techni-
que was assessed in comparison with intra-arterial me-
asurements [19]. The Portapres cuff was applied to the
middle finger of the non-dominant arm. The height
correction transducer was taped to the subject at the
chosen reference level, namely the anterior axillar line
at the height of the lower end of the sternum, and the
tube ending was fixed to the finger cuff. This height
correction system eliminated the need to keep the fin-
ger at heart level to prevent the occurrence of hydro-
static height differences between the finger cuff and the
heart [20]. Before each recording the Portapres was ca-
librated to obtain less than 5 mm Hg difference in com-
parison with sphygmomanometer measurement. Three
surface electrodes were fitted to the chest to record ECG
and respiratory activity. After ten minutes of familiari-
sation the data were collected.
Data collection consisted of 15 minutes of continu-
ous recordings with the subject in the sitting, supine
and standing position. Two stationary 5-minute frag-
ments (in the supine and standing positions) were ta-
ken for BRS analysis. Mean systolic and diastolic blood
pressure were evaluated on the basis of a one-minute
recording in the sitting position. Arterial pressure, ECG
and respiratory activity were visually monitored, digi-
tised at 300 samples per second and stored onto the hard
disk of a personal computer for offline analysis. Barore-
flex sensitivity was assessed by a frequency-domain
approach. This methodology has been described in de-
tail by others [21, 22]. Briefly, the analysis in the frequ-
ency domain was performed by splitting systolic blood
pressure (SBP) and RR interval signals into consecutive
segments of 512 beats and by removing the segments
containing non-stationarities. In the segments in which
around 0.1 Hz SBP and RR interval powers had a cohe-
rence > 0.5 the squared ratio between the powers of cor-
responding spectral components of the RR interval and
the SBP variabilities was computed. This provided the
á-coefficient used as an index of baroreflex sensitivity.
Traditional evaluation of autonomic
neuropathy (CAN)
The presence of autonomic neuropathy was assessed
by conventional tests as described by Ewing: deep bre-
athing, Valsalva manoeuvre, handgrip and standing.
These were adapted to the use of the Portapres device.
For each test we used the normative values provided
by Ewing. The results were classified as normal, bor-
derline or abnormal [8]. After Bellavere, a normal re-
sponse was graded as 0, a borderline as 1 and an abnor-
mal response as 2 points. Subjects with a total score equ-
al to or greater than 2 points were regarded as having
CAN [11].
Statistical analysis
The results are expressed as mean ±  SD. Between-gro-
up comparisons were made using Student’s unpaired
t-test (after testing for normality using the Shapiro-Wilk
test). For multiple comparisons variance analysis was
applied. A p value of less than 0.05 was regarded as sta-
tistically significant.
Results
The mean values of all Ewing’s tests were within the
normal ranges in the examined and control groups, al-
though the 30:15 ratio while standing up was signifi-
cantly lower in the diabetic patients (Table II). In diabe-
tic patients pathological and borderline responses were
observed in the handgrip test in 23.1% and 10.3 % sub-
jects respectively. Two subjects (5.1%) had pathologi-
cal and one (2.6%) had borderline results in the deep
breathing test. The Valsalva ratio was abnormal in two
patients (5.1%).
Ten diabetic patients (25.6%) had a total score be-
tween 2 and 4 points and these were classified as ha-
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ving CAN (the CAN(+) group). In the control group
borderline responses in the handgrip test were obse-
rved in 38.1% subjects. None of the healthy subjects
exhibited a pathological score. The characteristics of the
CAN(+) and CAN(–) groups in comparison with the
control group are shown in Table III. In the CAN(+)
group BRS was significantly lower in the supine and
standing positions than in the CAN(–) group and con-
trol subjects. There were no significant differences in
BRS in either position between the CAN(–) group and
healthy controls (Fig. 1).
Discussion
Arterial baroreceptors play an important role in the
short-term regulation of arterial pressure. They are
stretch receptors that respond to arterial distension de-
termined by intravascular pressure. Baroreceptors co-
nvey impulses to the nucleus tractus solitarius in the
brain stem. Afferent stimuli from baroreceptors are
transmitted via the vagus nerve (to form the carotid si-
nus receptors) and via nerve fibres that join the glosso-
pharyngeal nerve (to form the aortic arch barorecep-
tors) and finally reach the vagal nucleus. Vagal stimuli
decrease the heart rate. Nucleus tractus solitarius also
inhibits sympathetic centres, resulting in vasodilatation
and a reduction in the sympathetic stimulation of the
heart [23]. Impaired baroreceptor function in diabetes
is probably due to both structural and functional changes
in the neural pathways of the baroreflex arch [16, 24].
Our study was an attempt to determine the value of
BRS in the early detection of CAN in patients with type 1
diabetes. In our study all three groups of subjects, na-
mely CAN(+), CAN(–) and controls, were comparable
in age and blood pressure. The CAN(+) and CAN(–)
groups were also comparable in diabetes duration, gly-
caemic control (HbA1c) and BMI. BRS differentiated well
the CAN(+) group from the CAN(–) group. We did not,
however, find any differences in BRS between diabetic
patients without CAN and the control group.
There are discrepancies between our results and
those of the study by Frattola et al. [15]. In this study
BRS was significantly lower in the group of diabetic
patients with no abnormalities in standard cardiovascu-
lar tests than in healthy subjects. In Frattola’s study the
group of diabetics consisted of insulin-dependent and
non-insulin-dependent subjects. We wanted to assess
cardiac autonomic function in a homogenous group of
diabetics and so recruited only patients with type 1 dia-
betes. The differences in characteristics of the groups
studied make the results obtained in the two studies
difficult to compare. However, a group of type 1 diabetic
patients without microvascular complications similar to
ours was studied by Weston et al. [16]. In this group, who
did not give evidence of CAN in standard cardiovascu-
lar tests, BRS was significantly reduced in the supine and
standing positions in comparison with controls.
The results obtained by Frattola and Weston [15, 16],
which contrast with our own, indicate that estimation
of baroreflex cardiac modulation by joint analysis of blo-
od pressure and RR interval fluctuations is more sensi-
Figure 1. BRS in the supine and standing positions in the CAN(+)
and CAN(–) groups in comparison with the control subjects
Rycina 1. BRS w pozycji leżącej i po pionizacji u chorych na
cukrzycę CAN(+) i CAN(–) w porównaniu z osobami z grupy
kontrolnej
Table III. The characteristics of the diabetic subjects with
(CAN(+)) and without (CAN(–)) cardiovascular autonomic
neuropathy in comparison with control subjects
Tabela III. Charakterystyka grupy chorych na cukrzycę
w zależności odobecności neuropatii autonomicznej sercowo-
-naczyniowej (CAN(+) i CAN(–)) w porównaniu z grupą
kontrolną
CAN(+) CAN(–) Control
n = 10 n = 29 subjects
n = 18
Male/female 3/7 9/20 6/12
Age [years] 28.8±7.0 30.5±7.0 31.4±9.3
Diabetes duration 14.6±8.6 11.2±6.2 –
[years]
Height [cm] 172.1±9.6 169.7±8.5 170.9±9.2
Weight [kg] 68.9±16.6 69.4±11.8 64.7±13.7
BMI [kg/m2] 22.9±3.2 24.0a±2.6 22.0a±3.3
HbA1c [%] 7.8±2.3 7.5±1.8 –
SBP [mm Hg] 112.1±17.2 111.1±19.2 112.7±8.7
DBP [mm Hg] 63.0±10.4 61.5±11.9 61.0±10.0
Data are shown as mean values ± SD; n — the number of subjects in
a given condition; BMI — body mass index; P — systolic blood pressure;
P — diastolic blood pressure (average values of the 1 min recording by
Portapres in the sitting position), a < 0.05
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tive in detecting cardiac autonomic dysfunction than
traditional autonomic tests. In the study by Frattola et
al. BRS was also more sensitive in detecting autonomic
neuropathy than quantification of RR interval variabi-
lity [15]. On the other hand, Ducher et al. showed in
a small study of 13 diabetic patients that BRS did not
differ in 5 diabetic patients with pathological Ewing sco-
res compared to the remaining diabetic patients and to
healthy subjects. In Ducher’s study pathological or bor-
derline responses were also observed in healthy sub-
jects. None of these subjects, however, exhibited a pa-
thological score [18]. Similarly, in our study borderline
results of the handgrip test were found in the control
group, and the total score did not enable CAN to be
diagnosed either.
Variations in the results of cardiovascular autono-
mic tests conducted on healthy subjects confirm that
these results depend on the co-operation of the sub-
jects. The presence of peripheral sensory neuropathy
may also influence the results, particularly those of the
handgrip test. Ducher’s study indicates that in asympto-
matic patients the results of cardiovascular autonomic
tests may not reflect alterations in cardiac autonomic
function. The author suggests that the results obtained
by both Ewing’s tests and the assessment of BRS be com-
pared before a diagnosis of CAN is established [18].
Cardiovascular autonomic function tests are still re-
commended in the diagnosis of CAN [10]. These tests
have a prognostic value. It has been demonstrated that
abnormalities in cardiovascular tests are strongly asso-
ciated with an increased risk of silent myocardial ischa-
emia and mortality [1, 5]. Reduced BRS is a strong risk
factor for cardiac death in patients after myocardial in-
farction and with heart failure [25]. We have some evi-
dence that a blunted BRS is associated with an adverse
prognosis in diabetes [26]. In diabetic patients the pro-
gnostic value of BRS should, however, be confirmed in
follow-up studies in larger cohorts. Normal values and
standards of assessment of BRS should also be provi-
ded. Thus we do not have adequate evidence to base
a diagnosis of CAN on the assessment of BRS alone.
Conclusions
BRS differentiated well subjects with CAN from those
without. In this study we did not confirm, however, the
value of BRS in the early detection of autonomic dys-
function among patients with type 1 diabetes who sho-
wed no abnormalities in standard cardiovascular tests.
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